Trademark: 90979096
Word
MYRIAD GENETICS
Status Date
Tuesday, March 21, 2023
Registration Number
7007667
Registration Date
Tuesday, March 21, 2023
Filing Date
Wednesday, April 21, 2021
Published for Opposition
Tuesday, November 30, 2021
5 Medical test kits comprising chemical reagents and chemical preparations for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; medical diagnostic reagents, assays, chemical preparations, and diagnostic test kits consisting primarily of reagents for medical diagnostic purposes, namely, testing of fluids; chemical reagents for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic test kits comprised of chemical reagents and chemical preparations for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic kits consisting primarily of reagents for body fluid analysis and nucleic acid analysis and for detecting genetic conditions, disorders, and diseases for medical use
10 Medical test kits comprising specimen collection tubes and containers for collecting patient specimens, printed test forms, printed mailing materials, and printed user information inserts used in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; sample preparation device for medical diagnostic uses; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of tissue-based diagnostic testing, cytology and cell-based testing; blood, urine, and saliva medical specimen collection kits consisting of test tubes and self-mailer, used for health and genetic analysis and diagnostics
The mark consists of the word "MYRIAD" with the "M" appearing as a capital letter formed by four (4) lines that do not touch, and the remainder of the word appearing in lowercase letters, and the word "GENETICS" directly below "MYRIAD" appearing in lowercase letters.
"GENETICS"
Mar 21, 2023
Notice Of Registration Confirmation Emailed
Mar 21, 2023
Registered-Principal Register
Feb 14, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 13, 2023
Allowed Principal Register - Sou Accepted
Feb 4, 2023
Notice Of Design Search Code E-Mailed
Feb 4, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 3, 2023
Statement Of Use Processing Complete
Dec 15, 2022
Use Amendment Filed
Feb 3, 2023
Divisional Processing Complete
Dec 15, 2022
Divisional Request Received
Feb 3, 2023
Sou Extension 2 Granted
Dec 15, 2022
Sou Extension 2 Filed
Jan 25, 2023
Case Assigned To Intent To Use Paralegal
Dec 15, 2022
Teas Request To Divide Received
Dec 15, 2022
Teas Extension Received
Dec 15, 2022
Teas Statement Of Use Received
Jul 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 25, 2022
Sou Extension 1 Granted
Jul 25, 2022
Sou Extension 1 Filed
Jul 25, 2022
Teas Extension Received
Jun 17, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 17, 2022
Teas Change Of Correspondence Received
Jun 17, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 17, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 17, 2022
Teas Change Of Owner Address Received
Jan 27, 2022
Teas Change Of Correspondence Received
Jan 27, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Jan 27, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 27, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 25, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 30, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 30, 2021
Published For Opposition
Nov 10, 2021
Notification Of Notice Of Publication E-Mailed
Oct 25, 2021
Approved For Pub - Principal Register
Oct 25, 2021
Examiner's Amendment Entered
Oct 25, 2021
Notification Of Examiners Amendment E-Mailed
Oct 25, 2021
Examiners Amendment E-Mailed
Oct 25, 2021
Examiners Amendment -Written
Sep 8, 2021
Notification Of Non-Final Action E-Mailed
Sep 8, 2021
Non-Final Action E-Mailed
Sep 8, 2021
Non-Final Action Written
Sep 6, 2021
Assigned To Examiner
Jul 29, 2021
Notice Of Design Search Code E-Mailed
Jul 28, 2021
New Application Office Supplied Data Entered
Apr 24, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
